NeuroDerm
Drug-device combination therapies for central nervous system disorders.
NeuroDerm manufactures drug-device combination therapies for central nervous system disorders from its Rehovot operations. The company supplies healthcare systems, laboratories, OEM partners or regulated export customers across its listed primary markets.
- Type
- Manufacturer
- Location
- Rehovot, Israel
- Founded
- 2003
- Website
- neuroderm.com
- Categories
- Medical & Healthcare Supplies
- Markets
- Israel, United States, Germany, Japan
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-09 Mail server of the company domain
- domain-registered (green), checked 2026-08-09 Domain registry record
- lei-lapsed (amber), checked 2026-08-23 GLEIF global LEI register (golden copy)
- debarment-clear (green), checked 2026-08-09 OpenSanctions
- sanctions-clear (green), checked 2026-08-09 OpenSanctions
Claimed certifications
- Good Manufacturing Practice
- ISO 13485, Medical Devices Quality IAF CertSearch
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)